Pfizer Inc (PFE)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 88,203,000 | 89,014,000 | 95,661,000 | 77,201,000 | 63,238,000 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $88,203,000K)
= 0.00
The debt-to-capital ratio for Pfizer Inc for the years 2020, 2021, 2022, 2023, and 2024 is consistently 0.00. This indicates that the company has not relied on debt to finance its operations and investments during these periods, as its total debt is negligible in relation to its total capital. A debt-to-capital ratio of 0.00 is generally considered very low and suggests that Pfizer Inc has a strong financial position with a significant proportion of capital funded by equity rather than debt. Investors and creditors may view this positively as it indicates lower financial risk and potentially greater stability for the company.
Peer comparison
Dec 31, 2024